Amnis Introduces New FlowSight Imaging Flow Cytometer

13 Jun 2011
bridget bridget
Laboratory Director

Amnis Corporation, a manufacturer of advanced cell imaging systems, today announced the launch of the new FlowSight imaging flow cytometer.

The FlowSight is a compact and affordable 12-channel flow cytometer with unrivalled fluorescence sensitivity and the breakthrough ability to produce imagery of every cell. The modular FlowSight can be upgraded in the factory or the field with up to four lasers, a 96-well AutoSampler, and a Quantitative Imaging package, thereby providing the capabilities and flexibility to meet the needs of a broad range of users.

“With 12 detection channels, visual verification of every cell, and affordable pricing, the FlowSight is designed to serve the needs of beginners and expert flow cytometrists alike,” said David Basiji, Ph.D., Amnis’ Chief Executive Officer. Basiji added, “The FlowSight complements Amnis' flagship ImageStreamX imaging flow cytometer, a high resolution microscope for cells in fluid suspension that enables numerous image-based assays in rare sub-populations.”

“The FlowSight is based on the proven ImageStreamX architecture and shares its remarkable fluorescence sensitivity, exceeding that of high-end conventional flow cytometers by five-fold or more,” remarked William Ortyn, Amnis’ President and COO. “With the FlowSight, Amnis is fulfilling its promise to bring cell imaging to the larger flow cytometry market,” added Ortyn.

Image Stream®X Mark II Imaging Flow Cytometer

Merck

The revolutionary ImageStream®X Mark II Imaging Flow Cytometer combines the speed, sensitivity, and phenotyping abilities of flow cytometry with the detailed imagery and functional insights of microscopy. This unique combination enables a broad range of applications that would be impossible using either technique alone. This instrument produces multiple high-resolution images of every cell directly in flow, including brightfield and darkfield (SSC), and up to 10 fluorescent markers with sensitivity exceeding conventional flow cytometers. Compared to its predecessor, the new ImageStream®X Mark II Imaging Flow Cytometer offers a streamlined workflow, greater flexibility, and optimizations for rare cell applications. Taken together, the capabilities of the ImageStream®X Mark II make it superior for traditional flow applications while greatly expanding the scope of flow cytometry. Applications include the study of cell-cell interactions, phagocytosis, apoptosis and autophagy, the characterization of circulating tumor cells, and many others.

(1)

Flowsight® Imaging Flow Cytometer

Merck

The FlowSight flow cytometer offers high performance in a small package. Its innovative design increases signal and minimizes noise to provide unmatched fluorescence sensitivity. Twelve standard detection channels simultaneously produce brightfield, darkfield and up to ten channels of fluorescence imagery of every cell. With these unique capabilities, the FlowSight enables a broad range of applications. Intuitive: Easy-to-use, with imagery for every cell:The FlowSight operates like a conventional flow cytometer but also provides imagery of every cell. Powerful and intuitive analysis software seamlessly links quantitative data to imagery: Click on a dot in any plot to see the corresponding cell imagery. Click on a bin in any histogram to view all the cells in that bin. Draw gates on dot plots and view the resulting populations to validate results. Affordable: Designed and priced for every lab: The FlowSight is powerful enough for the core lab but sized and priced for any lab. The system can be factory configured or field upgraded with up to four excitation lasers (405, 488, 561, 642 nm), a 96-well plate AutoSampler, and a powerful quantitative image processing option. Whether in a base configuration or fully-optioned, the FlowSight sets a new standard of value.

(1)

Links

Tags

Amnis Introduces New FlowSight Imaging Flow Cytometer